$PWUP News
Last published 1y ago
- 1y agoASBPPWUPAspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase AgreementACCESS NewswireNEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. , a developer of a multi-faceted patent-protected disruptive drug delivery mechanism
- 1y agoPWUPAspire Biopharma Holdings, Inc., Announces Public Listing on NasdaqACCESS NewswireNEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Aspire Biopharma, Inc. , a developer of a multi-faceted patent-protected disruptive drug delivery mechanism
- 1y agoCGBDNBRPALTPWUPKuehn Law Encourages NBR, PALT, CGBD, and PWUP Investors to Contact Law FirmGlobeNewswireNEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 2y agoPWUPAspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and SupplementsGlobeNewswireHighlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of approximately $316 million.Industry-Leading Platform: Aspire is focused on developing a pipeline of
- 2y agoPWUPAspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.GlobeNewswireHumacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent protected disruptive drug delivery mechanism technology, and
- 2y agoPWUPPowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-QGlobeNewswireNew York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the "Company") (NASDAQ:PWUP) announced today that, on June 3, 2024, the Company received a notice (the "Notice") from the Nasdaq Listing
- 2y agoPWUPPowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of ShareholdersGlobeNewswireNew York, NY, May 20, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the "Company") (NASDAQ:PWUP) announced today that its extraordinary general meeting of shareholders (the "Meeting"), which was originally
- 2y agoPWUPPowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of ShareholdersGlobeNewswireNew York, NY, May 16, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the "Company") (NASDAQ:PWUP) announced today that its extraordinary general meeting of shareholders (the "Meeting"), which was originally
- 2y agoPWUPPowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business CombinationGlobeNewswireTarrytown, NY and New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. ("PowerUp") (NASDAQ:PWUP) and Visiox Pharmaceuticals, Inc. ("Visiox"), a commercial-stage biopharmaceutical company, today
- 2y agoPWUPVisiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.GlobeNewswireTarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Visiox Pharmaceuticals, Inc. ("Visiox" or the "Company"), a commercial-stage biopharmaceutical company, and PowerUp Acquisition Corp. ("PowerUp")